| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| ACTBP2 |
|
ACTB pseudogene 2
|
|
|
0.861 |
0.077 |
| ADH1C |
P00326
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
Enzyme
|
|
0.547 |
0.731 |
| ATD |
|
asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome)
|
|
|
0.656 |
0.731 |
| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| CTAG1B |
P78358
|
cancer/testis antigen 1B
|
|
|
0.507 |
0.731 |
| CYP2D7 |
A0A087X1C5
|
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)
|
|
|
0.659 |
0.577 |
| FPR1 |
P21462
|
formyl peptide receptor 1
|
G-protein coupled receptor
|
|
0.576 |
0.769 |
| FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
| FUT5 |
Q11128
|
fucosyltransferase 5
|
Enzyme
|
|
0.760 |
0.115 |
| GAGE7 |
A1L429 O76087 P0CL80 P0CL81 P0CL82
|
G antigen 7
|
|
|
0.760 |
0.269 |
| GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| HLA-H |
P01893
|
major histocompatibility complex, class I, H (pseudogene)
|
|
|
0.736 |
0.500 |
| HOXB@ |
|
homeobox B cluster
|
|
|
0.631 |
0.538 |
| HSP90AA2P |
Q14568
|
heat shock protein 90 alpha family class A member 2, pseudogene
|
Chaperone
|
|
0.760 |
0.269 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA8 |
P32881
|
interferon alpha 8
|
|
|
0.839 |
0.115 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| IFNW1 |
P05000
|
interferon omega 1
|
|
|
0.743 |
0.346 |
| IGHE |
P01854
|
immunoglobulin heavy constant epsilon
|
|
|
0.626 |
0.538 |